J. Moraleda

发表

Amniotic membrane stimulates cell migration by modulating transforming growth factor‐β signalling

Diego Angosto, F. J. Nicolás, C. Ruiz-Cañada, 2018, Journal of tissue engineering and regenerative medicine.

Genetic and phenotypic characterisation of HIV‐associated aggressive B‐cell non‐Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications

J. Briones, J. Gribben, S. Montoto, 2022, Histopathology.

Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome

E. Andreu, F. Fernández‐Avilés, A. Zapata, 2022, Frontiers in Immunology.

Amniotic membrane promotes focal adhesion remodeling to stimulate cell migration

J. Moraleda, F. J. Nicolás, Á. Bernabé-García, 2017, Scientific Reports.

An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion

J. Monserrat, M. Blanquer, C. Insausti, 2012, Transfusion.

Large‐volume‐apheresis facilitates autologous transplantation of hematopoietic progenitors in poor mobilizer patients

A. Minguela, J. Moraleda, M. Blanquer, 2009, Journal of clinical apheresis.

Ixazomib Plus Lenalidomide/Dexamethasone (IRd) Versus Lenalidomide /Dexamethasone (Rd) Maintenance after Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma: Results of the Spanish GEM2014MAIN Trial

A. Oriol, J. Bargay, J. Martí, 2021, Blood.

Assessment of Treatment Response By Ife, Next Generation Flow Cytometry and Mass Spectrometry Coupled with Liquid Chromatography in the GEM2012MENOS65 Clinical Trial

N. Puig, A. Oriol, B. Paiva, 2021, Blood.

A randomized phase II study comparing consolidation with a single dose of 90Y ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

J. Briones, A. López-Guillermo, A. Salar, 2021, Leukemia & lymphoma.

Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study

J. Sancho, M. Federico, M. Ramírez, 2022, Haematologica.

Response to Maccio et al, “Multifactorial pathogenesis of COVID‐19‐related coagulopathy: Can defibrotide have a role in the early phases of coagulation disorders?”

M. Díaz-Ricart, C. Carlo-Stella, G. Yanik, 2020, Journal of Thrombosis and Haemostasis.

Results from a Pilot Study of ARI0002h, an Academic BCMA-Directed CAR-T Cell Therapy with Fractionated Initial Infusion and Booster Dose in Patients with Relapsed and/or Refractory Multiple Myeloma

F. Prósper, M. Juan, B. Paiva, 2021, Blood.

Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation

G. Salles, S. Montoto, A. Nagler, 2018, Bone Marrow Transplantation.

Comparative Effects between Bone Marrow and Mesenchymal Stem Cell Transplantation in GDNF Expression and Motor Function Recovery in a Motorneuron Degenerative Mouse Model

J. Moraleda, J. Jaramillo-Merchán, D. Pastor, 2011, Stem Cell Reviews and Reports.

Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV).

M. Juan, L. Badimón, A. Zapata, 2023, Bone marrow transplantation.

Correlative Biological Studies Related to the Response, Peak and Persistence of ARI0002h, an Academic BCMA-Directed CAR-T Cell, with Fractionated Initial Infusion and Booster Dose for Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

F. Prósper, M. Juan, B. Paiva, 2021, Blood.

Circulating Tumor Cells (CTCs) in Smoldering and Active Multiple Myeloma (MM): Mechanism of Egression, Clinical Significance and Therapeutic Endpoints

H. Goldschmidt, A. Órfão, N. Puig, 2021, Blood.

N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study

M. Blanquer, I. Español, F. García-Candel, 2023, Annals of Hematology.

Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma: a study on behalf of the Chronic malignancies working party of the EBMT.

J. Bourhis, I. Yakoub-Agha, D. Mclornan, 2023, Bone marrow transplantation.

Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application

M. Blanquer, C. Insausti, A. García-Hernández, 2014 .

Amniotic membrane-derived stem cells: immunomodulatory properties and potential clinical application

M. Blanquer, C. Insausti, A. García-Hernández, 2014 .

Amniotic membrane-derived stem cells : immunomodulatory properties and potential clinical application

M. Blanquer, C. Insausti, A. García-Hernández, 2014 .

Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.

M. Juan, B. Paiva, J. Pérez-Simón, 2023, The Lancet. Oncology.

Genetic and phenotypic characterisation of HIV‐associated aggressive B‐cell non‐Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications

J. Briones, J. Gribben, S. Montoto, 2022, Histopathology.

Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance

Marco S. Nobile, D. Besozzi, N. Puig, 2023, Nature communications.

Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects

J. Moraleda, J. I. Gil-Chinchilla, Agustín G. Zapata, 2024, Biomolecules.

Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome.

J. Garcia-conde, M. Terol, F. Hernández-Navarro, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide.

M. Iacobelli, M. Kocoglu, C. Mo, 2024, Blood reviews.

Amniotic Membrane Restores Chronic Wound Features to Normal in a Keratinocyte TGF-β-Chronified Cell Model

F. J. Nicolás, Á. Bernabé-García, S. Liarte, 2023, International journal of molecular sciences.

Flow Cytometry as a New Accessible Method to Evaluate Diagnostic Osmotic Changes in Patients with Red Blood Cell Membrane Defects

A. B. Pérez-Oliva, Maria Sanchez-Villalobos, J. Moraleda, 2024, Biomedicines.